XML 51 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share-based awards
The following grants of share-based awards were made in 2017 under the 2005 Incentive Plan: 
Date of Grant
 
 
Shares
 
 
 
Grant Date
Fair Value
Per Share
 
 
Vesting Period
 
 
 
 
 
 
 
 
 
 
 
January 3, 2017 (1)
 
 
671,771

 
 
 
$
8.82

 
 
33% per year over three years
January 3, 2017 (2)
 
 
671,771

 
 
 
$
12.64

 
 
100% on January 1, 2020
January 3, 2017 (3)
 
 
9,956

 
 
 
$
8.82

 
 
100% on January 1, 2019
April 3, 2017 (3)
 
 
8,004

 
 
 
$
7.77

 
 
100% on January 1, 2019
July 3, 2017 (3)
 
 
14,018

 
 
 
$
5.64

 
 
100% on January 1, 2019
October 2, 2017 (3)
 
 
7,654

 
 
 
$
7.39

 
 
100% on January 1, 2019
December 7, 2017 (4)
 
 
117,740

 
 
 
$
6.37

 
 
100% on December 7, 2018
(1)
Reflects grants of restricted stock to our executive officers and select management employees.
(2)
Reflects grants of PSUs to our executive officers and select management employees.
(3)
Reflects grants of restricted stock to certain independent members of our Board who have made an election to take their quarterly fees in stock in lieu of cash.
(4)
Reflects annual equity grants to each independent member of our Board.
Summary of information about restricted stock
The following table summarizes information about our restricted stock: 
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
Shares
 
Grant Date
Fair Value (1)
 
Shares
 
Grant Date
Fair Value (1)
 
Shares
 
Grant Date
Fair Value (1)
 
 
 
 
 
 
 
 
 
 
 
 
Awards outstanding at beginning of year
1,577,973

 
$
7.86

 
661,124

 
$
16.28

 
554,960

 
$
17.54

Granted
829,143

 
8.39

 
1,298,121

 
5.70

 
501,076

 
15.57

Vested (2)
(817,791
)
 
8.84

 
(305,588
)
 
16.94

 
(332,223
)
 
16.44

Forfeited
(10,107
)
 
7.01

 
(75,684
)
 
7.76

 
(62,689
)
 
20.93

Awards outstanding at end of year
1,579,218

 
$
7.63

 
1,577,973

 
$
7.86

 
661,124

 
$
16.28

(1)
Represents the weighted average grant date fair value, which is based on the quoted closing market price of our common stock on the trading day prior to the date of grant.
(2)
Total fair value of restricted stock that vested during the years ended December 31, 2017, 2016 and 2015 was $6.9 million, $2.2 million and $5.1 million, respectively.